Lannett’s common shares have begun trading in the over-the-counter market after the New York Stock Exchange suspended the company’s shares from its exchange and moved to delist the struggling US-based generics player.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?